Hashem Haghdoost-Yazdi - Publications, H-index & Citations

Hashem Haghdoost-Yazdi

qazvin university of medical sciences (qums)

15H指数

60论文数

526被引数

收录论文 11

发表时间

RETRACTION: Dopaminergic Neuronal Death in Substantia Nigra Associates with Serum Levels of Total Bilirubin, Selenium, and Zinc: Evidences from 6-Hydroxydopamine Animal Model of Parkinson's Disease (Retraction of Vol 200, Pg 4058, 2021)

BIOLOGICAL TRACE ELEMENT RESEARCH

IF3.6

2024-05-29

OAAI

Sophiabadi, Mohammad; Rastgoo, Nafiseh; Haghdoost-Yazdi, Hashem

Unraveling the function and structure impact of deleterious missense SNPs in the human OX1R receptor by computational analysis

SCIENTIFIC REPORTS

IF3.9

2024-01-08

OAAI

Farajzadeh-Dehkordi, Mahvash; Mafakher, Ladan; Harifi, Abbas; Haghdoost-Yazdi, Hashem; Piri, Hossein; Rahmani, Babak

RETRACTION: Chronic and progressive dopaminergic neuronal death in substantia nigra associates with a decrease in serum levels of glucose and free fatty acids, the role of interlokin-1 beta (Retraction of Vol 37, Pg 373, 2021)

METABOLIC BRAIN DISEASE

IF3.5

2023-09-26

OAAI

Sarbazi-Golezari, Ali; Haghdoost-Yazdi, Hashem

RETRACTED: Chronic and progressive dopaminergic neuronal death in substantia nigra associates with a decrease in serum levels of glucose and free fatty acids, the role of interlokin-1 beta (Retracted Article)

METABOLIC BRAIN DISEASE

IF3.5

2021-11-12

PREAI

Sarbazi-Golezari, Ali; Haghdoost-Yazdi, Hashem

RETRACTED: Dopaminergic Neuronal Death in Substantia Nigra Associates with Serum Levels of Total Bilirubin, Selenium, and Zinc: Evidences from 6-Hydroxydopamine Animal Model of Parkinson's Disease 撤回: 黑质中的多巴胺能神经元死亡与血清总胆红素，硒和锌的水平有关: 来自帕金森氏病的6-羟基多巴胺动物模型的证据

BIOLOGICAL TRACE ELEMENT RESEARCH

IF3.6

2021-11-06

PREAI

Sophiabadi, Mohammad; Rastgoo, Nafiseh; Haghdoost-Yazdi, Hashem

Hydrogen sulfide attenuates induction and prevents progress of the 6-hydroxydopamine-induced Parkinsonism in rat through activation of ATP-sensitive potassium channels and suppression of ER stress

TOXICOLOGY AND APPLIED PHARMACOLOGY

IF3.4

2021-07-01

PREAI

Minaei, Azita; Sarookhani, Mohammad Reza; Haghdoost-Yazdi, Hashem; Rajaei, Farzad

Dexmedetomidine attenuates the induction and reverses the progress of 6-hydroxydopamine- induced parkinsonism; involvement of KATP channels, alpha 2 adrenoceptors and anti-inflammatory mechanisms

TOXICOLOGY AND APPLIED PHARMACOLOGY

IF3.4

2019-11-01

PREAI

Minaei, Azita; Haghdoost-Yazdi, Hashem

Changes in the Serum Urate Level Can Predict the Development of Parkinsonism in the 6-Hydroxydopamine Animal Model

NEUROCHEMICAL RESEARCH

IF3.8

2018-04-03

PREAI

Sarukhani, Mohammad Reza; Haghdoost-Yazdi, Hashem; Khandan-Chelarci, Gilda

Evaluation of the association between blood homocysteine concentration and the degree of behavioral symptoms in the 6-hydroxydopamine-induced Parkinsonism in rat

PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

IF2.5

2014-09-01

PREAI

Haghdoost-Yazdi, Hashem; Sarookhani, Mohammad; Faraj, Ayda; Fraidouni, Negin; Dargahi, Tahereh; Yaghoubidoust, Mohammad Hosein; Azhdari-Zarmehri, Hassan

Orexin receptor type-1 antagonist SB-334867 decreases morphine-induced antinociceptive effect in formalin test

PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

IF2.5

2013-11-01

PREAI

Azhdari-Zarmehri, Hassan; Esmaeili, Mohammad-Hossein; Sofiabadi, Mohammad; Haghdoost-Yazdi, Hashem

In vivo 4-aminopyridine treatment alters the neurotoxin 3-acetylpyridine-induced plastic changes in intrinsic electrophysiological properties of rat cerebellar Purkinje neurones

EUROPEAN JOURNAL OF PHARMACOLOGY

IF4.7

2010-09-01

PREAI

Goudarzi, Iran; Kaffashian, Mohammadreza; Shabani, Mohammad; Haghdoost-Yazdi, Hashem; Behzadi, Gila; Janahmadi, Mahyar

研究方向